Massive study reveals how SMA patients fare on modern drugs
NCT ID NCT07403214
Summary
This study looked back at the real-world experiences of 4,805 people with spinal muscular atrophy (SMA) who received one or more of three modern drug treatments. It aimed to understand how often patients needed hospital care or special medical equipment before and after starting treatment. By analyzing health insurance claims data, researchers tracked treatment patterns and health outcomes to learn how these drugs perform outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR ATROPHY, SPINAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.